Cargando…

Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes

The complexity and overall burden of Parkinson’s disease (PD) require new pharmacological approaches to counteract the symptomatology while reducing the progressive neurodegeneration of affected dopaminergic neurons. Since the pathophysiological signature of PD is characterized by the loss of physio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padilla-Godínez, Francisco J., Ruiz-Ortega, Leonardo I., Guerra-Crespo, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657131/ https://www.ncbi.nlm.nih.gov/pubmed/36359841 http://dx.doi.org/10.3390/cells11213445

Ejemplares similares

Emerging two-dimensional material nanozymes for theranostic nanomedicine
por: You, Yanling, et al.
Publicado: (2021)

Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action
por: López-Goerne, Tessy, et al.
Publicado: (2023)

Nanomedicine Faces Barriers
por: Debbage, Paul, et al.
Publicado: (2010)

Development of Drug Delivery Systems Based on Layered Hydroxides for Nanomedicine
por: Barahuie, Farahnaz, et al.
Publicado: (2014)

Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
por: Wang, Qi, et al.
Publicado: (2023)

Nanocomposites as biomolecules delivery agents in nanomedicine
por: Bamburowicz-Klimkowska, Magdalena, et al.
Publicado: (2019)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Nanomedicine: Revolutionary trends in drug delivery and diagnostics
por: Nagaich, Upendra
Publicado: (2014)

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
por: Kang, Xuejia, et al.
Publicado: (2023)

Bioorthogonal catalytic nanozyme-mediated lysosomal membrane leakage for targeted drug delivery
por: Sun, Zhiyuan, et al.
Publicado: (2022)

Drug delivery, biomaterials and nanomedicine: an interview with Daniel S Kohane
por: Kohane, Daniel S
Publicado: (2016)

Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017)

HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021)

Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
por: Rommasi, Foad, et al.
Publicado: (2021)

Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012)

Nanomedicine in pulmonary delivery
por: Mansour, Heidi M, et al.
Publicado: (2009)

Nanomedicines for the Delivery of Biologics
por: Wahlich, John, et al.
Publicado: (2019)

Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
por: Ranganathan, Ramya, et al.
Publicado: (2012)

Editorial: Nanomedicine-Based Drug Delivery Systems: Recent Developments and Future Prospects
por: Shakeel, Faiyaz
Publicado: (2023)

Drug Delivery Strategies and Nanozyme Technologies to Overcome Limitations for Targeting Oxidative Stress in Osteoarthritis
por: Aldrich, Jessica Lee, et al.
Publicado: (2023)

Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery
por: Cao, Ziyang, et al.
Publicado: (2022)

Cancer nanomedicine: a review of recent success in drug delivery
por: Tran, Stephanie, et al.
Publicado: (2017)

Inner ear barriers to nanomedicine-augmented drug delivery and imaging()
por: Zou, Jing, et al.
Publicado: (2016)

Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
por: Khiev, Dawin, et al.
Publicado: (2021)

Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
por: Andreana, Ilaria, et al.
Publicado: (2021)

Recent Advances of Microfluidic Platforms for Controlled Drug Delivery in Nanomedicine
por: Ejeta, Fikadu
Publicado: (2021)

A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine
por: Jahangirian, Hossein, et al.
Publicado: (2017)

Protein Misfolding and Aggregation: The Relatedness between Parkinson’s Disease and Hepatic Endoplasmic Reticulum Storage Disorders
por: Padilla-Godínez, Francisco J., et al.
Publicado: (2021)

Nanomedicine for the Delivery of RNA in Cancer
por: Ghidini, Michele, et al.
Publicado: (2022)

Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions
por: Trac, Noah, et al.
Publicado: (2023)

Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems
por: Hajialyani, Marziyeh, et al.
Publicado: (2018)

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
por: Jagaran, Keelan, et al.
Publicado: (2021)

Nanomedicine for drug delivery in South Africa: a protocol for systematic review
por: Saidi, Trust, et al.
Publicado: (2018)

Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
por: Man, Francis, et al.
Publicado: (2018)

Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
por: Choi, Young Hee, et al.
Publicado: (2017)

Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery
por: Wang, Sheng, et al.
Publicado: (2020)

Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
por: Li, Jin, et al.
Publicado: (2020)

Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
por: Tawfik, Mohamed, et al.
Publicado: (2022)

Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
por: Yan, Cen, et al.
Publicado: (2019)

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control
por: Hussain, Afzal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vagmusbd2ka0gtif9jkjq6ttbq